Citation: S. Rozenberg et al., Constant estrogen, intermittent progestogen vs. continuous combined hormone replacement therapy: tolerability and effect on vasomotor symptoms, INT J GYN O, 72(3), 2001, pp. 235-243
Authors:
Chitrit, Y
Caubel, P
Herrero, R
Schwinte, AL
Guillaumin, D
Boulanger, MC
Citation: Y. Chitrit et al., Effects of maternal dexamethasone administration on fetal Doppler flow velocity waveforms, BR J OBST G, 107(4), 2000, pp. 501-507
Authors:
Chitrit, Y
Guillaumin, D
Caubel, P
Herrero, R
Citation: Y. Chitrit et al., Absence of flow velocity waveform changes in uterine arteries after bilateral internal iliac artery ligation, AM J OBST G, 182(3), 2000, pp. 727-728
Citation: Ra. Lobo et al., A novel intermittent regimen of norgestimate to preserve the beneficial effects of 17 beta-estradiol on lipid and lipoprotein profiles, AM J OBST G, 182(1), 2000, pp. 41-49
Citation: Sl. Corson et al., Effect of a unique constant-estrogen. Pulsed-progestin hormone replacementtherapy containing 17 beta-estradiol and norgestimate on endometrial histology, INT J F W M, 44(6), 1999, pp. 279-285
Citation: Pj. Sulak et al., Efficacy and safety of a constant-estrogen, pulsed-progestin regimen in hormone replacement therapy, INT J F W M, 44(6), 1999, pp. 286-296